scispace - formally typeset
Search or ask a question
Institution

Medical University of Graz

EducationGraz, Steiermark, Austria
About: Medical University of Graz is a education organization based out in Graz, Steiermark, Austria. It is known for research contribution in the topics: Population & Medicine. The organization has 5684 authors who have published 12349 publications receiving 417282 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The dysregulation of the growth factors and their receptors may be involved in placental and fetal changes observed in diabetes, i.e. enhanced placentaland fetal growth, placental hypervascularization and higher levels of fetal plasma amino acids.
Abstract: The insulin/insulin-like growth factor (IGF) system regulates fetal and placental growth and development. In maternal diabetes, components of this system including insulin, IGF1, IGF2 and various IGF-binding proteins are deregulated in the maternal or fetal circulation, or in the placenta. The placenta expresses considerable amounts of insulin and IGF1 receptors at distinct locations on both placental surfaces. This makes the insulin and the IGF1 receptor accessible to fetal and/or maternal insulin, IGF1 and IGF2. Unlike the receptor for IGF1, the insulin receptor undergoes a gestational change in expression site from the trophoblast at the beginning of pregnancy to the endothelium at term. Insulin and IGFs are implicated in the receptor-mediated regulation of placental growth and transport, trophoblast invasion and placental angiogenesis. The dysregulation of the growth factors and their receptors may be involved in placental and fetal changes observed in diabetes, i.e. enhanced placental and fetal growth, placental hypervascularization and higher levels of fetal plasma amino acids.

189 citations

Journal ArticleDOI
TL;DR: A systematic review of studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureteretectomy could be extended to selected cases of aggressive tumours.

188 citations

Journal ArticleDOI
H. Wedemeyer1, Ann-Sofi Duberg2, Maria Buti, William Rosenberg3, S. Frankova, Gamal Esmat4, Necati Örmeci5, H. Van Vlierberghe6, Michael Gschwantler, Ulus Salih Akarca7, Soo Aleman8, Soo Aleman9, İsmail Balik5, Thomas Berg10, Florian Bihl, Marc Bilodeau11, Antonio Javier Blasco, C. E. Brandão Mello12, Philip Bruggmann, Filipe Calinas, Jose Luis Calleja, Hugo Cheinquer13, Peer Brehm Christensen14, Mette Rye Clausen, Henrique Sérgio Moraes Coelho15, Markus Cornberg1, Matthew E. Cramp16, Gregory J. Dore17, Wahid Doss4, Manal H El-Sayed18, Gül Ergör19, Chris Estes, Karolin Falconer8, J. Félix, Maria Lucia Gomes Ferraz20, Paulo R. Ferreira20, Javier García-Samaniego21, Jan Gerstoft22, José Giria, Fernando L. Gonçales23, M Guimarães Pessôa24, Christophe Hézode, S. J. Hindman, Harald Hofer25, Petr Husa26, Ramazan Idilman5, Martin Kåberg8, Kelly Kaita27, Achim Kautz, Sabahattin Kaymakoglu28, Mel Krajden29, Henrik Krarup30, Wim Laleman31, Daniel Lavanchy, Pablo Lázaro, Rui Tato Marinho, Paul Marotta32, S. Mauss33, M. C. Mendes Correa24, Christophe Moreno34, Beat Müllhaupt35, Robert P. Myers36, Vratislav Nemecek, Anne Øvrehus14, J Parkes, Kevork M. Peltekian37, Alnoor Ramji29, Homie Razavi, N. Reis, Stuart K. Roberts38, Françoise Roudot-Thoraval, Stephen D. Ryder39, Rui Sarmento-Castro, Christoph Sarrazin40, David Semela41, Morris Sherman42, Gamal Shiha, Jan Sperl, Peter Stärkel43, Rudolf E. Stauber44, Alexander J. Thompson45, Petr Urbánek46, P. Van Damme47, I. van Thiel, Dominique Vandijck48, Wolfgang Vogel, Imam Waked, Nina Weis49, Johannes Wiegand10, Ayman Yosry4, Amany Zekry17, Francesco Negro50, William Sievert38, E. Gower 
TL;DR: It is possible to achieve elimination of HCV (defined as a >90% decline in total infections by 2030), however, for most countries presented, this will require a 3–5 fold increase in diagnosis and/or treatment.
Abstract: The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis suggests that successful diagnosis and treatment of a small proportion of patients can contribute significantly to the reduction of disease burden in the countries studied. The largest reduction in HCV-related morbidity and mortality occurs when increased treatment is combined with higher efficacy therapies, generally in combination with increased diagnosis. With a treatment rate of approximately 10%, this analysis suggests it is possible to achieve elimination of HCV (defined as a >90% decline in total infections by 2030). However, for most countries presented, this will require a 3-5 fold increase in diagnosis and/or treatment. Thus, building the public health and clinical provider capacity for improved diagnosis and treatment will be critical.

188 citations

Journal ArticleDOI
TL;DR: Over the 10-year study period, accuracy in melanoma detection improved only in specialized clinics maybe because of a larger use of new diagnostic techniques such as dermatoscopy.
Abstract: Background Early excision is the only strategy to reduce melanoma mortality, but unnecessary excision of benign lesions increases morbidity and healthcare costs. Objective To assess accuracy in melanoma detection based on number-needed-to-excise (NNE) values over a 10-year period. Methods Information was retrieved on all histopathologically confirmed cutaneous melanomas or melanocytic nevi that were excised between 1998 and 2007 at participating clinics. NNE values were calculated by dividing the total number of excised lesions by the number of melanomas. Analyses included changes in NNE over time, differences in NNE between specialized clinical settings (SCS) versus non-specialized clinical settings (NSCS), and patient factors influencing NNE. Results The participating clinics contributed a total of 300,215 cases, including 17,172 melanomas and 283,043 melanocytic nevi. The overall NNE values achieved in SCS and NSCS in the 10-year period were 8.7 and 29.4, respectively. The NNE improved over time in SCS (from 12.8 to 6.8), but appeared unchanged in NSCS. Most of the effect on NNE in SCS was due to a greater number of excised melanomas. Higher NNE values were observed in patients younger than 40 years and for lesions located on the trunk. Limitations No data concerning the use of dermatoscopy and digital monitoring procedures were collected from the participating centers. Conclusion Over the 10-year study period, accuracy in melanoma detection improved only in specialized clinics maybe because of a larger use of new diagnostic techniques such as dermatoscopy.

186 citations


Authors

Showing all 5763 results

NameH-indexPapersCitations
Ian J. Deary1661795114161
James F. Wilson146677101883
Nancy L. Pedersen14589094696
William Wijns12775295517
Andrew Simmons10246036608
Franz Fazekas10162949775
Hans-Peter Hartung10081049792
Michael Trauner9866735543
Dietmar Fuchs97111939758
Funda Meric-Bernstam9675336803
Ulf Landmesser9456446096
Aysegul A. Sahin9332230038
Frank Madeo9226945942
Takayoshi Ohkubo9163169634
Jürgen C. Becker9063728741
Network Information
Related Institutions (5)
Mayo Clinic
169.5K papers, 8.1M citations

94% related

Brigham and Women's Hospital
110.5K papers, 6.8M citations

94% related

Baylor College of Medicine
94.8K papers, 5M citations

93% related

Beth Israel Deaconess Medical Center
52.5K papers, 2.9M citations

93% related

Boston Children's Hospital
215.5K papers, 6.8M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202334
2022116
20211,411
20201,227
20191,015
2018917